EP2715359A4 - Verfahren und zusammensetzungen zur überwachung von therapiemitteln und zu ihrer dosierung durch pharmakokinetische profilierung am pflegeort - Google Patents

Verfahren und zusammensetzungen zur überwachung von therapiemitteln und zu ihrer dosierung durch pharmakokinetische profilierung am pflegeort

Info

Publication number
EP2715359A4
EP2715359A4 EP12792802.6A EP12792802A EP2715359A4 EP 2715359 A4 EP2715359 A4 EP 2715359A4 EP 12792802 A EP12792802 A EP 12792802A EP 2715359 A4 EP2715359 A4 EP 2715359A4
Authority
EP
European Patent Office
Prior art keywords
dosing
care
compositions
methods
point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12792802.6A
Other languages
English (en)
French (fr)
Other versions
EP2715359A1 (de
Inventor
Vuong Ngoc Trieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autotelic LLC
Original Assignee
STRING THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STRING THERAPEUTICS Inc filed Critical STRING THERAPEUTICS Inc
Publication of EP2715359A1 publication Critical patent/EP2715359A1/de
Publication of EP2715359A4 publication Critical patent/EP2715359A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
EP12792802.6A 2011-05-30 2012-05-30 Verfahren und zusammensetzungen zur überwachung von therapiemitteln und zu ihrer dosierung durch pharmakokinetische profilierung am pflegeort Withdrawn EP2715359A4 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161491268P 2011-05-30 2011-05-30
US201161514488P 2011-08-03 2011-08-03
US201161526950P 2011-08-24 2011-08-24
US201161533250P 2011-09-11 2011-09-11
US201161577008P 2011-12-17 2011-12-17
US201261606371P 2012-03-03 2012-03-03
US201261615312P 2012-03-25 2012-03-25
US201261635730P 2012-04-19 2012-04-19
PCT/US2012/039993 WO2012166795A1 (en) 2011-05-30 2012-05-30 Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling

Publications (2)

Publication Number Publication Date
EP2715359A1 EP2715359A1 (de) 2014-04-09
EP2715359A4 true EP2715359A4 (de) 2015-01-21

Family

ID=47259824

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12792802.6A Withdrawn EP2715359A4 (de) 2011-05-30 2012-05-30 Verfahren und zusammensetzungen zur überwachung von therapiemitteln und zu ihrer dosierung durch pharmakokinetische profilierung am pflegeort

Country Status (6)

Country Link
EP (1) EP2715359A4 (de)
JP (2) JP6184943B2 (de)
CN (1) CN104160274A (de)
AU (2) AU2012262322B2 (de)
CA (1) CA2837331A1 (de)
WO (1) WO2012166795A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135189L (fi) 2013-02-28 2014-08-29 iStoc Oy Kannettava lateraalinen koetulosten lukija
US20150154375A1 (en) * 2013-11-27 2015-06-04 Companion Dx Reference Lab, Llc. Systems and methods for optimizing drug therapies
JP2017513030A (ja) * 2014-04-04 2017-05-25 オートテリック エルエルシー パクリタキセルの薬物動態ガイド下投薬のための血漿中パクリタキセル濃度のモニタリングのための方法、デバイス、および試薬
US9714953B2 (en) 2014-04-04 2017-07-25 Autotelic Llc Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel
WO2016114761A1 (en) * 2015-01-13 2016-07-21 Autotelic Llc Method for individualized drug therapy
WO2015191460A1 (en) * 2014-06-08 2015-12-17 Autotelic Llc Fixed dose combination for pain relief without edema
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
WO2016057679A1 (en) * 2014-10-09 2016-04-14 LuminaCare Solutions Inc. Personalized antibiotic dosing platform
WO2016115057A1 (en) * 2015-01-13 2016-07-21 Autotelic Llc Fixed dose combination for pain relief without edema
CN104899458B (zh) * 2015-06-16 2017-09-15 中国环境科学研究院 评价纳米金属氧化物健康效应的qsar毒性预测方法
TW201718656A (zh) 2015-10-07 2017-06-01 奧托德里克有限公司 用於結合紫杉醇之以抗體為主的親和性試劑
US20200306211A1 (en) * 2015-11-30 2020-10-01 Pharnext Method for adapting doses of combination therapies
WO2017123550A1 (en) 2016-01-11 2017-07-20 Autotelic Llc Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
WO2017151892A2 (en) 2016-03-02 2017-09-08 Waters Technologies Corporation Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry
EA201892347A1 (ru) 2016-04-15 2019-04-30 Баксалта Инкорпорейтед Способ и устройство для предоставления фармакокинетической схемы дозирования лекарственных препаратов
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
CN108593828A (zh) * 2018-02-23 2018-09-28 李水军 血浆制备卡中药物和毒物含量的检测方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (en) * 2003-04-10 2004-10-28 Ivax Research, Inc. Taxane-based compositions and methods of use
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075174A (ja) * 1993-06-18 1995-01-10 Nippon Steel Corp 高検出能イムノアッセイ法
US6594168B2 (en) * 1997-05-30 2003-07-15 Micron Technology, Inc. 256 Meg dynamic random access memory
CN1154491C (zh) * 1998-11-04 2004-06-23 法玛西雅厄普约翰美国公司 用于改善替普拉那维的药物动力学的方法
HUP0300333A3 (en) * 1999-05-11 2009-01-28 Ortho Mcneil Pharm Inc Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
CN1615130A (zh) * 2001-12-28 2005-05-11 Ivax研究公司 基于紫杉烷的组合物及使用方法
EP1497647A1 (de) * 2002-04-19 2005-01-19 Pfizer Products Inc. Verfahren zur bestimmung von therapeutischen drogenspiegeln
KR20040101344A (ko) * 2002-04-19 2004-12-02 인터내셔널 비지네스 머신즈 코포레이션 마이크로프로세서, 인스트럭션 시퀀스 발생 방법 및 이를구현한 프로그램 디바이스
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
CA2554779A1 (en) * 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US20060024768A1 (en) * 2004-07-29 2006-02-02 Saladax Biomedical, Inc. Taxol immunoassay
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060264779A1 (en) * 2005-05-09 2006-11-23 Kemp Timothy M Fluidic medical devices and uses thereof
WO2007058896A2 (en) * 2005-11-10 2007-05-24 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment
CN101437541A (zh) * 2006-03-03 2009-05-20 伊兰药品公司 用那他珠单抗治疗炎性疾病和自身免疫病的方法
US20070237719A1 (en) * 2006-03-30 2007-10-11 Jones Christopher M Method and system for monitoring and analyzing compliance with internal dosing regimen
NZ595809A (en) * 2009-04-30 2013-02-22 Purdue Research Foundation Ion generation using wetted porous material
CA2768488A1 (en) * 2009-07-17 2011-01-20 Myriad Genetics, Inc. Method of assaying 5-fu

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (en) * 2003-04-10 2004-10-28 Ivax Research, Inc. Taxane-based compositions and methods of use
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012166795A1 *

Also Published As

Publication number Publication date
JP6184943B2 (ja) 2017-08-23
WO2012166795A1 (en) 2012-12-06
AU2012262322A1 (en) 2014-01-23
CN104160274A (zh) 2014-11-19
EP2715359A1 (de) 2014-04-09
JP2014518375A (ja) 2014-07-28
CA2837331A1 (en) 2012-12-06
AU2012262322B2 (en) 2016-11-03
AU2016277632A1 (en) 2017-01-19
JP2017207508A (ja) 2017-11-24

Similar Documents

Publication Publication Date Title
EP2715359A4 (de) Verfahren und zusammensetzungen zur überwachung von therapiemitteln und zu ihrer dosierung durch pharmakokinetische profilierung am pflegeort
AP3864A (en) Pharmaceutical composition
PL2776416T3 (pl) Związki farmaceutyczne
EP2756855A4 (de) Medikamenteneinspritzvorrichtung
IL230861A (en) A rapidly dissolving pharmaceutical composition
GB201118232D0 (en) Pharmaceutical composition
EP2702989A4 (de) Stabile pharmazeutische zusammensetzung
EP2767257A4 (de) Artikulator
HK1201534A1 (en) Pharmaceutical compounds
HK1189158A1 (en) Pharmaceutical composition
GB201119799D0 (en) Pharmaceutical compounds
GB2525835B (en) Pharmaceutical agent
EP2731610A4 (de) Pharmazeutische kombination
GB201113163D0 (en) Pharmaceutical compounds
GB201118876D0 (en) Pharmaceutical compounds
EP2727593A4 (de) Nicorandil enthaltende pharmazeutische zusammensetzung
HK1174525A1 (zh) 咬合器
EP2711010A4 (de) Pharmazeutische zusammensetzung
HUP1100444A2 (en) Pharmaceutical composition
BR112013022907A2 (pt) composição farmacêutica
PL2709470T3 (pl) System dozowania tytoniu
PL2709599T3 (pl) Kompozycja farmaceutyczna zawierająca drotawerynę
HUP1100445A2 (en) Pharmaceutical composition
GB201108234D0 (en) Pharmaceutical agent
GB201119796D0 (en) Pharmaceutical comopounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20150105

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101ALI20141218BHEP

Ipc: G01N 33/543 20060101AFI20141218BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AUTOTELIC LLC

17Q First examination report despatched

Effective date: 20160712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180825